Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.66% | 196.94 | 1.3% | $565.97m | |
| GILD | Gilead Sciences, Inc. | 0.70% | 66.42 | 0.9% | $368.71m | |
| BIIB | Biogen Inc. | 1.35% | 238.79 | 1.3% | $340.32m | |
| ILMN | Illumina, Inc. | 1.43% | 309.57 | 3.5% | $338.07m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.62% | 106.32 | 2.0% | $332.28m | |
| CELG | Celgene Corporation | 0.42% | 99.37 | 1.3% | $309.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.40% | 295.87 | 2.6% | $188.33m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.12% | 178.12 | 1.9% | $186.01m | |
| A | Agilent Technologies, Inc. | -0.18% | 77.93 | 1.6% | $185.14m | |
| EXAS | Exact Sciences Corporation | 0.55% | 103.97 | 24.1% | $152.91m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.34% | 82.51 | 14.6% | $139.60m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -2.26% | 40.74 | 13.9% | $129.03m | |
| INCY | Incyte Corporation | 3.96% | 81.21 | 2.5% | $93.98m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.11% | 18.64 | 10.2% | $81.98m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.38% | 74.95 | 4.3% | $76.08m |
Company Profile
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.